◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
华兰疫苗 — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017
+Revenue 1.1B 2.4B 1.8B 1.8B 2.4B 1.0B 803.0M 285.0M
Revenue Growth % -53.2% 32.0% -0.2% -24.6% 131.3% 30.6% 181.8% --
Total Revenue 1.1B 2.4B 1.8B 1.8B 2.4B 1.0B 803.0M 285.0M
Cost Of Revenue 213.0M 287.0M 217.0M 221.0M 258.0M 161.0M 127.0M 87.9M
+Gross Profit 915.0M 2.1B 1.6B 1.6B 2.2B 888.0M 676.0M 197.1M
Gross Margin % 81.1% 88.1% 88.1% 87.9% 89.4% 84.7% 84.2% 69.2%
Total Operating Cost 1.0B 1.5B 1.3B 1.2B 1.4B 637.0M 570.0M 403.0M
Selling Expenses 501.0M 949.0M 681.0M 583.0M 865.0M 306.0M 337.0M 188.0M
Admin Expenses 81.2M 69.8M 95.7M 64.5M 50.0M 28.9M 22.7M 16.2M
Rd Expenses 163.0M 91.1M 135.0M 144.0M 111.0M 73.0M 53.0M 64.0M
Finance Expenses -7.1M -5.0M -5.5M 8.2M 647,900 -325,900 -154,000 -449,700
+Operating Income 215.0M 1.0B 593.0M 707.0M 1.1B 432.0M 300.0M -101.0M
Operating Margin % 19.1% 41.9% 32.5% 38.6% 44.3% 41.2% 37.4% -35.4%
Non Operating Income 1.6M -- 311,400 34.00 300,000 220,000 1.8M 1.5M
Non Operating Expenses 1.9M 3.2M 3.5M 1.2M 335,700 186,500 272,500 496,900
Investment Income 76.1M 70.5M 55.6M 23.8M 8.1M 10.6M 13.9M 14.4M
Fair Value Change Income 24.3M 39.7M 16.8M 14.2M 1.9M 4.7M -- --
Asset Disposal Income -140,100 -198,900 627,200 -- -- -- 51,000 -439,200
Asset Impairment Loss 74.2M 94.9M 152.0M 133.0M 30.7M 49.6M 23.3M 43.3M
Other Income 12.9M 13.1M 10.0M 4.9M 10.1M 4.5M 52.8M 3.9M
Income Before Tax 215.0M 1.0B 589.0M 706.0M 1.1B 432.0M 301.0M -99.6M
Income Tax 9.0M 147.0M 69.8M 84.8M 149.0M 56.8M 31.2M -22.7M
+Net Income 206.0M 860.0M 520.0M 621.0M 925.0M 375.0M 270.0M -76.9M
Net Margin % 18.3% 35.7% 28.5% 33.9% 38.1% 35.7% 33.6% -27.0%
Net Income Attributable 206.0M 860.0M 520.0M 621.0M 925.0M 375.0M 270.0M -76.9M
Eps Basic 0.34 1.43 0.88 1.72 2.57 1.04 0.75 -0.21
Eps Diluted 0.34 1.43 0.88 1.72 2.57 1.04 0.75 -0.21
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017
Cash And Equivalents 623.0M 641.0M 600.0M 132.0M 412.0M 279.0M 143.0M 26.6M
Trading Financial Assets 1.5B 1.6B 1.4B 826.0M 453.0M 222.0M -- --
Accounts Receivable 1.4B 2.0B 1.8B 1.4B 1.5B 689.0M 540.0M 172.0M
Notes Receivable -- -- -- -- -- -- 470,000 913,000
Notes And Accounts Receivable 1.4B 2.0B 1.8B 1.4B 1.5B 689.0M 540.0M 173.0M
Prepayments 56.9M 28.2M 20.2M 23.3M 22.9M 10.1M 14.9M 8.9M
Inventory 209.0M 173.0M 167.0M 107.0M 45.3M 55.8M 78.4M 59.6M
Total Current Assets 5.0B 5.2B 4.2B 2.5B 2.5B 1.3B 988.0M 550.0M
Fixed Assets -- 1.2B 1.3B 1.3B 493.0M 267.0M 214.0M 157.0M
Fixed Assets Total 1.1B 1.2B 1.3B 1.3B 493.0M 267.0M 214.0M 157.0M
Construction In Progress -- 3.2M 3.3M -- 316.0M 79.5M 36.6M 37.8M
Construction In Progress Total 6.7M 3.2M 3.3M -- 316.0M 79.5M 36.6M 37.8M
Intangible Assets 20.9M 20.1M 20.8M 21.4M 22.1M 22.7M 23.4M 24.0M
Long Term Deferred Expenses -- 1.7M 4.5M 10.8M -- -- -- --
Total Non Current Assets 2.5B 2.8B 2.9B 2.0B 1.2B 532.0M 380.0M 296.0M
Total Assets 7.5B 8.0B 7.1B 4.5B 3.6B 1.8B 1.4B 846.0M
Short Term Borrowings 300.0M 300.0M 300.0M 500.0M 200.0M -- -- --
Accounts Payable 81.8M 117.0M 110.0M 161.0M 34.4M 15.3M 20.1M 17.3M
Advance Receipts -- -- -- -- -- -- 3.5M 2.4M
Contract Liabilities 8.7M 2.7M 2.7M 1.5M 1.9M 3.4M -- --
Total Current Liabilities 1.5B 1.7B 1.5B 1.7B 1.5B 531.0M 481.0M 229.0M
Total Non Current Liabilities 46.0M 46.6M 42.1M 43.2M 6.3M 699,800 -- --
Total Liabilities 1.5B 1.7B 1.6B 1.7B 1.5B 532.0M 481.0M 229.0M
Paid In Capital 601.0M 600.0M 400.0M 360.0M 360.0M 100.0M 100.0M 100.0M
Capital Reserve 2.9B 2.9B 3.1B 880.0M 880.0M -- -- --
Surplus Reserve 301.0M 286.0M 200.0M 157.0M 94.7M 50.0M 50.0M 47.6M
Retained Earnings 2.3B 2.5B 1.8B 1.4B 853.0M 1.1B 737.0M 469.0M
Equity Attributable 6.0B 6.3B 5.5B 2.8B 2.2B 1.3B 887.0M 617.0M
Total Equity 6.0B 6.3B 5.5B 2.8B 2.2B 1.3B 887.0M 617.0M
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017
Cash From Sales 1.8B 2.3B 1.5B 2.0B 1.6B 916.0M 438.0M 225.0M
Total Operating Cash Inflow 1.8B 2.3B 1.5B 2.0B 1.6B 923.0M 494.0M 243.0M
Cash Paid For Goods 253.0M 242.0M 343.0M 317.0M 172.0M 88.9M 63.8M 38.9M
Cash Paid To Employees 95.5M 99.6M 110.0M 115.0M 102.0M 105.0M 68.4M 50.3M
Taxes Paid 151.0M 192.0M 172.0M 296.0M 197.0M 136.0M 30.0M 12.2M
Total Operating Cash Outflow 1.4B 1.4B 1.2B 1.5B 952.0M 648.0M 399.0M 221.0M
Operating Cash Flow 468.0M 888.0M 289.0M 569.0M 694.0M 275.0M 94.5M 22.2M
Total Investing Cash Inflow 19.4B 4.2B 5.2B 3.1B 2.3B 1.1B 557.0M 699.0M
Total Investing Cash Outflow 19.5B 4.9B 6.9B 4.2B 3.0B 1.3B 536.0M 639.0M
Investing Cash Flow -61.1M -721.0M -1.8B -1.1B -753.0M -141.0M 21.2M 59.0M
Cash From Borrowings -- 300.0M 300.0M 800.0M 250.0M -- -- --
Dividends And Interest Paid 334.0M 126.0M 90.9M 12.8M 4.6M -- -- 100.0M
Debt Repayments -- 300.0M 500.0M 500.0M 50.0M -- -- --
Total Financing Cash Inflow 16.3M 300.0M 2.6B 800.0M 250.0M -- -- --
Total Financing Cash Outflow 441.0M 426.0M 603.0M 514.0M 114.0M -- -- 100.0M
Financing Cash Flow -425.0M -126.0M 2.0B 286.0M 136.0M -- -- -100.0M
Net Change In Cash -17.9M 40.9M 485.0M -236.0M 76.1M 135.0M 116.0M -18.8M
Ending Cash Balance 623.0M 641.0M 600.0M 115.0M 351.0M 275.0M 141.0M 24.9M
Capex 51.6M 62.6M 92.6M 636.0M 532.0M 144.0M 62.8M 25.6M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...